The existing oral and intravenous forms of bumetanide are commonly prescribed for people with heart failure because they ease tissue swelling, a common cause of symptoms for people with heart failure.

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according ...

There is no cure for heart failure and it typically gets worse over time with around half of patients dying within five years ...

From swollen ankles to a persistent cough, these 5 subtle signs could reveal you are at risk of heart failure long before you ...

The NHS is warning people to be vigilant for a potentially fatal symptom that could indicate heart failure. The health body ...

The NHS has issued a warning to be vigilant over an uncomfortable symptom in the legs that could indicate a potentially ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

Over 90% of type 2 diabetes patients face an increased risk of heart disease due to high blood sugar's impact on blood ...

indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Bumetanide injection USP (RLD Bumex) had an estimated annual ...

The Platte Valley Medical Clinic announces the launch of its Heart Failure Clinic, dedicated to providing specialized care ...